compounding glp-1 Compounding: When Innovation May Mean Liability FDA and Novo Nordisk Warned

The recommended dosage for Semaglutide is as follows: 0.25 mg once weekly for the first 4 weeks 0.5 mg once weekly for at least 4 weeks 1 mg once weekly for at least 4 weeks, but only if additional glycemic control is needed 2mg once weekly if additional control is needed Semaglutide injections should be dosed subcutaneously

1 The NAD+ to NADH ratio is found to be reduced in some neurodegenerative diseases such as Parkinsons Disease, leading researchers to hypothesize that NAD+ replacement may lead to improvements

Hyder F, Rothman DL

doi: 10.1016/j.bbrc.2005.03.169 35 MiyazakiK

Injectable forms are now classified as Category 2 , restricting them from 503A pharmacy compounding

The supernatants and the lysates were stored at 80 C